Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Streptococcus pyogenes Infections - Overview
Streptococcus pyogenes Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Streptococcus pyogenes Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Streptococcus pyogenes Infections - Companies Involved in Therapeutics Development
Absynth Biologics Ltd
AstraZeneca Plc
Cadila Pharmaceuticals Ltd
Crestone Inc
Helix BioMedix Inc
Wellstat Vaccines LLC
Streptococcus pyogenes Infections - Drug Profiles
(mupirocin calcium + neomycin sulfate + HT-61) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AZ-6142 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HB-1345 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit PolC for Gram-Positive Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus [serotype A] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
streptococcus pyogenes (30-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes Infections - Dormant Projects
Streptococcus pyogenes Infections - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Streptococcus pyogenes Infections, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Streptococcus pyogenes Infections, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Streptococcus pyogenes Infections - Pipeline by Absynth Biologics Ltd, H2 2019
Streptococcus pyogenes Infections - Pipeline by AstraZeneca Plc, H2 2019
Streptococcus pyogenes Infections - Pipeline by Cadila Pharmaceuticals Ltd, H2 2019
Streptococcus pyogenes Infections - Pipeline by Crestone Inc, H2 2019
Streptococcus pyogenes Infections - Pipeline by Helix BioMedix Inc, H2 2019
Streptococcus pyogenes Infections - Pipeline by Wellstat Vaccines LLC, H2 2019
Streptococcus pyogenes Infections - Dormant Projects, H2 2019
Streptococcus pyogenes Infections - Discontinued Products, H2 2019